82 related articles for article (PubMed ID: 3860300)
1. [4'-epidoxorubicin].
Mechl Z
Cas Lek Cesk; 1985 Jun; 124(24):755-7. PubMed ID: 3860300
[No Abstract] [Full Text] [Related]
2. American symposium looks at new antineoplastic drug.
Korcok M
Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
[No Abstract] [Full Text] [Related]
3. [Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
Lopez M; Di Lauro L; Papaldo P; Lazzaro B
Clin Ter; 1984 Apr; 109(1):31-5. PubMed ID: 6233078
[No Abstract] [Full Text] [Related]
4. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
5. Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia.
Bonfante V; Bonadonna G; Villani F; Martini A
Recent Results Cancer Res; 1980; 74():192-9. PubMed ID: 6934564
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
Campora E; Nobile MT; Sertoli MR; Rosso R
Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
[No Abstract] [Full Text] [Related]
7. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
Ventura GJ
J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
[No Abstract] [Full Text] [Related]
8. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
[TBL] [Abstract][Full Text] [Related]
9. [New anthracyclines in the treatment of solid tumors in the advanced stage].
Pannuti F; Martoni A; Lelli G; Camaggi CM; Strocchi E; Fruet F
G Ital Chemioter; 1985; 32(1):49-56. PubMed ID: 3868636
[No Abstract] [Full Text] [Related]
10. Phase II clinical evaluation of 4'-epi-doxorubicin.
Hurteloup P; Cappelaere P; Armand JP; Mathé G
Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
[TBL] [Abstract][Full Text] [Related]
11. Caelyx and ovarian cancer.
Eur J Cancer Care (Engl); 2001 Jun; 10(2):79. PubMed ID: 11829050
[No Abstract] [Full Text] [Related]
12. Chemotherapy during pregnancy: what is really safe?
Peccatori F; Martinelli G; Gentilini O; Goldhirsch A
Lancet Oncol; 2004 Jul; 5(7):398. PubMed ID: 15231245
[No Abstract] [Full Text] [Related]
13. Liposomal doxorubicin in breast cancer: new preparation. Much ado about nothing.
Prescrire Int; 2003 Jun; 12(65):93-5. PubMed ID: 12825572
[TBL] [Abstract][Full Text] [Related]
14. Troponins for predicting cardiotoxicity from cancer therapy.
Sparano JA; Wolff AC; Brown D
Lancet; 2000 Dec; 356(9246):1947-8. PubMed ID: 11130520
[No Abstract] [Full Text] [Related]
15. [New 2004 guidelines of the Breast Organ Committee of AGO].
Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
[No Abstract] [Full Text] [Related]
16. A pilot study of epidoxorubicin (NSC 256942) in combination treatment of acute leukaemia and non-Hodgkin's lymphoma.
Eridani S; Pearson TC; Slater NG; Singh AK
Oncology; 1984; 41(6):383-6. PubMed ID: 6390286
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induced second degree and complete atrioventricular block.
Kilickap S; Akgul E; Aksoy S; Aytemir K; Barista I
Europace; 2005 May; 7(3):227-30. PubMed ID: 15878560
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of left ventricular function in patients with mammary carcinoma after treatment with epidoxorubicin using a high-dose, short-term protocol].
D'Alto M; Maurea S; Basso A; Polverino W; Bianchi U; Bonelli A; Silvestro P; Salvatore M; Chiariello M
Cardiologia; 1997 Jun; 42(6):611-8. PubMed ID: 9289377
[TBL] [Abstract][Full Text] [Related]
19. Pegylated liposomal doxorubicin hydrochloride (PLD) for advanced sarcomas in children: preliminary results.
Muñoz A; Maldonado M; Pardo N; Fernández JM; Vela E; Cubells J
Pediatr Blood Cancer; 2004 Aug; 43(2):152-5. PubMed ID: 15236282
[No Abstract] [Full Text] [Related]
20. Assessment of ventricular function by radionuclide angiography in patients receiving 4'-epidoxorubicin and mitoxantrone.
Vorobiof DA; Iturralde M; Falkson G
Cancer Chemother Pharmacol; 1985; 15(3):253-7. PubMed ID: 3863718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
